Treatment Preferences among Patients with Hormone-Sensitive Prostate Cancer in France, Spain, China, South Korea, and Japan: A Discrete-Choice Experiment.

ABSTRACT: Background. Treatment preferences of patients with high-risk localized prostate cancer (HRLPC) and metastatic hormone-sensitive prostate cancer (mHSPC) are expected to be influenced by cultural and institutional differences across countries. We aimed to evaluate this expectation by quantifying the importance of treatment outcomes for patients with HRLPC and mHSPC. Methods. A discrete-choice experiment survey included adults (≥18 y of age) diagnosed with HRLPC or mHSPC from 5 countries-France, Spain, China, South Korea, and Japan-with or without previous experience of androgen-deprivation therapy. A latent-class random-parameters logit model was used to evaluate the importance patients assigned to treatment attributes and the consistency in treatment preferences across the 5 c

SUBMITTER: Gonzalez JM 

PROVIDER: S-EPMC12598092 | biostudies-literature | 2025 Jul-Dec

REPOSITORIES: biostudies-literature